FDA approves wider range of treatments for cancer drug
The FDA's approval now includes treatment for types of colorectal cancer, gastrointestinal cancer, breast cancer, prostate cancer, bladder cancer, thyroid cancer and more. A addiction previously approved to treat different skin cancers recently got a Food and Drug Administration greenlight to treat a few more. This is the first time a drug has received FDA approval based on a genetic feature. Vugrin said Keytruda targets the T cells and makes them aware of the cancer and blocks them from aiding in the production of more cancer cells. "It's quite an exciting drug," Vugrin said.
A new drug that causes a person's skin to tan while also dramatically reducing the risk of skin cancer has been developed, scientists have said. "Dark pigment is associated with a lower risk of all forms of skin cancer - that would be really huge." "Our real goal is a novel strategy for protecting skin from UV radiation and cancer," Fisher said. However, Fisher also warned against the use of the drug as simply another means of cosmetically enhancing a person's skin. "It would not actually be a fake tan, it would be the real thing," Fisher said.
collected by :Lucy William
No comments:
Post a Comment